{"title":"Laryngeal non-Hodgkin lymphoma presenting as throat foreign body sensation: A case report.","authors":"Hongming Liao, Ai He, Fengbo Yan, Benchao He","doi":"10.1097/MD.0000000000043132","DOIUrl":null,"url":null,"abstract":"<p><strong>Rationale: </strong>Laryngeal lymphoma is an extremely rare malignancy, representing <1% of all laryngeal tumors. Diffuse large B-cell lymphoma (DLBCL) is the most common histologic subtype. Due to its rarity and nonspecific symptoms, early diagnosis and timely treatment are critical.</p><p><strong>Patient concerns: </strong>A 67-year-old male presented with progressive hoarseness and a persistent sensation of a foreign body in the throat that had developed over several weeks.</p><p><strong>Diagnoses: </strong>Laryngoscopy revealed a submucosal mass involving the glottis. Contrast-enhanced computed tomography demonstrated soft tissue infiltration. Surgical excision was performed, and histopathological evaluation confirmed the diagnosis of diffuse large B-cell lymphoma of the larynx.</p><p><strong>Interventions: </strong>The patient received systemic chemotherapy tailored to the staging and anatomical location of the lymphoma, following current DLBCL treatment guidelines.</p><p><strong>Outcomes: </strong>The patient experienced significant symptom relief after chemotherapy, with resolution of hoarseness and foreign body sensation. No recurrence was observed during the 2-month follow-up period.</p><p><strong>Lessons: </strong>This case highlights the importance of considering lymphoma in the differential diagnosis of persistent hoarseness and throat discomfort. Early biopsy and multidisciplinary intervention are essential to achieve favorable outcomes in patients with rare laryngeal DLBCL.</p>","PeriodicalId":18549,"journal":{"name":"Medicine","volume":"104 26","pages":"e43132"},"PeriodicalIF":1.3000,"publicationDate":"2025-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12212830/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/MD.0000000000043132","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
Abstract
Rationale: Laryngeal lymphoma is an extremely rare malignancy, representing <1% of all laryngeal tumors. Diffuse large B-cell lymphoma (DLBCL) is the most common histologic subtype. Due to its rarity and nonspecific symptoms, early diagnosis and timely treatment are critical.
Patient concerns: A 67-year-old male presented with progressive hoarseness and a persistent sensation of a foreign body in the throat that had developed over several weeks.
Diagnoses: Laryngoscopy revealed a submucosal mass involving the glottis. Contrast-enhanced computed tomography demonstrated soft tissue infiltration. Surgical excision was performed, and histopathological evaluation confirmed the diagnosis of diffuse large B-cell lymphoma of the larynx.
Interventions: The patient received systemic chemotherapy tailored to the staging and anatomical location of the lymphoma, following current DLBCL treatment guidelines.
Outcomes: The patient experienced significant symptom relief after chemotherapy, with resolution of hoarseness and foreign body sensation. No recurrence was observed during the 2-month follow-up period.
Lessons: This case highlights the importance of considering lymphoma in the differential diagnosis of persistent hoarseness and throat discomfort. Early biopsy and multidisciplinary intervention are essential to achieve favorable outcomes in patients with rare laryngeal DLBCL.
期刊介绍:
Medicine is now a fully open access journal, providing authors with a distinctive new service offering continuous publication of original research across a broad spectrum of medical scientific disciplines and sub-specialties.
As an open access title, Medicine will continue to provide authors with an established, trusted platform for the publication of their work. To ensure the ongoing quality of Medicine’s content, the peer-review process will only accept content that is scientifically, technically and ethically sound, and in compliance with standard reporting guidelines.